- Hyaluronic acid syringe (hexadecylamide sodium hyaluronate) Hymovis Hyadd4 is a medical device for intraarticular injection. The product reduces pain in osteoarthritis and also contributes to the improvement of joint mobility.
Hymovis Hyadd4 composition:
Hyadd4 (hexadecylamide sodium hyaluronate) - 24mg / 3ml and other ingredients: sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.
Operation Hymovis Hyadd4:
Hymovis Hyadd4 is a medical device in the form of a sterile, non-pyrogenic hydrogel, which contains Hyadd4 in isotonic buffer solution. Hyadd4 is a hexadecylamide of highly purified, natural sodium hyaluronate obtained in the process of bacterial fermentation. This component, due to its high viscosity and elasticity, improves hydration and shock absorption by the synovial fluid. In other words, it protects cartilage and soft tissues from mechanical injuries. The preparation relieves pain, brings relief and improves the functioning of joints with short-term treatment.
Application:
Medical device Hymovis Hyadd4 indicated for use in the treatment of pain, which occurs in the course of osteoarthritis, as well as for use to improve joint mobility by increasing the viscoelasticity of the synovial fluid.
Additional information:
Keep the product out of reach of children at room temperature. It is recommended to protect against moisture and light. With exudate: remove exudate before Hymovis is given. Treatment should be avoided in case of visible symptoms of acute inflammation of the joint.
Contraindications:
Do not use in case of hypersensitivity to any component of the product. Do not administer extravagantly or intravenously. Do not use if the joint is infected or covered by serious inflammation. Do not use if an active disease or skin infection is present at the injection site (and its vicinity).
How to use Hymovis Hyadd4 pre-filled syringes:
For local use - delivery. Cycle of treatment: two injections, one week apart. The product may only be administered by qualified medical personnel. The preparation should be injected slowly into the affected joint, use a suitable sterile needle (18G or 20G). During the procedure, the application techniques and aseptic rules should be followed.